Business Context and Reporting Period
This Form 6-K filing by Atlas Critical Minerals Corp (ATCX) covers the month of January 2026. The Company, a foreign private issuer based in Brazil, announced the pricing and closing of a public offering of its common stock on the Nasdaq Capital Market.
Key Financial Metrics
The filing details a capital raise event rather than operational financial results. Key figures include:
- Gross Proceeds: Approximately $11.0 million.
- Net Proceeds: Approximately $9.7 million.
- Shares Sold: 1,200,000 initial shares plus 180,000 shares from the full exercise of the over-allotment option (total 1,380,000 shares).
- Offering Price: $8.00 per share.
- Financial Advisory Fee: $135,000 paid to A.G.P.
The filing text does not provide clear values for revenue, profit, operating cash flow, margins, or existing debt levels, as this report focuses solely on the equity offering.
Material Changes
The primary material change is the successful completion of a $11.0 million public offering, which significantly increased the Company's cash reserves. The Company also granted underwriters warrants to purchase up to 82,800 shares (6.0% of the offering) at an exercise price of $9.20, subject to a 180-day lock-up period.
Guidance, Outlook, and Risks
Use of Proceeds: Management intends to use net proceeds to advance exploration and development activities across its critical minerals project portfolio in Brazil. Any surplus will be used for general working capital, cash reserves, or other corporate purposes.
Risks and Contingencies: The filing notes that the Underwriting Agreement contains customary representations and warranties but explicitly states these are not intended as factual information for investors regarding the Company's current state of affairs. Investors are directed to other Commission filings for business and financial details.
Investor Verification Checklist
- Verify the final share count and dilution impact of the 1,380,000 shares issued.
- Confirm the specific allocation of the $9.7 million net proceeds to individual Brazilian projects.
- Review the Company's most recent Form 20-F for baseline financial data (revenue, debt, cash position) prior to this offering.
- Monitor the 180-day non-exercisable period for the Representative's Warrants and the potential future dilution if exercised.